Logo

Hyaluronan-mediated CD44 Receptor Cancer Cells Progression and the Application of Controlled Drug-delivery System

Abdullah, MA (2010) Hyaluronan-mediated CD44 Receptor Cancer Cells Progression and the Application of Controlled Drug-delivery System. [Citation Index Journal]

[img] PDF (International Journal of Current Chemistry : Vol. 1, No. 4, October-December 2010)
Restricted to Registered users only

344Kb

Abstract

Hyaluronan (HA) is a major component of extracellular matrix (ECM) and main ligand of CD44 receptor cells. CD44 belongs to multifunctional transmembrane protein family expressed in both normal and tumor cells. HA is expressed more in cancer cells as compared to normal cells. HA binding to CD44 mediate oncogenic signaling, metastasis and cytoskeleton activation leading to tumor invasion and growth of tumor cells. HA-CD44 binding and Cytoskeleton signaling pathways are important targets for anti-cancer drug development to curb tumor invasion and metastasis. A polymer drug delivery system such as “Dendrimers” can possibly combat deadly cancer. Globular macromolecular versatile polymer having multivalent, monodisperse and highly branched carrier molecule will play a major role in targeted control drug delivery against cancer.

Item Type:Citation Index Journal
Subjects:R Medicine > R Medicine (General)
Departments / MOR / COE:Mission Oriented Research > Health
ID Code:6380
Deposited By: Dr Mohd Azmuddin Abdullah
Deposited On:05 Sep 2011 00:38
Last Modified:19 Jan 2017 08:24

Repository Staff Only: item control page

Document Downloads

More statistics for this item...